Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene
about
UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patientsExpression of the androgen metabolizing enzyme UGT2B15 in adipose tissue and relative expression measurement using a competitive RT-PCR methodUDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cellsCellular specific expression of the androgen-conjugating enzymes UGT2B15 and UGT2B17 in the human prostate epitheliumCloning and characterization of a simian UDP-glucuronosyltransferase enzyme UGT2B20, a novel C19 steroid-conjugating proteinMolecular cloning, expression and characterization of a monkey steroid UDP-glucuronosyltransferase, UGT2B19, that conjugates testosterone.Functions and transcriptional regulation of PAH-inducible human UDP-glucuronosyltransferases.Functional glycosylation in the human and mammalian uterus.UDP-glucuronosyltransferase 1A10: activity against the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and a potential role for a novel UGT1A10 promoter deletion polymorphism in cancer susceptibility.The effect of UGT1A and UGT2B polymorphisms on colorectal cancer risk: haplotype associations and gene–environment interactions.Structural and functional studies of UDP-glucuronosyltransferases.Tobacco carcinogen-detoxifying enzyme UGT1A7 and its association with orolaryngeal cancer risk.Allelic imbalance (AI) identifies novel tissue-specific cis-regulatory variation for human UGT2B15Polymorphisms in UDP glucuronosyltransferase genes: functional consequences and clinical relevance.A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple Loci implicated in sex steroid hormone regulationHuman hepatic UGT2B15 developmental expression.Prognostic significance of ESR1 amplification and ESR1 PvuII, CYP2C19*2, UGT2B15*2 polymorphisms in breast cancer patients.Uridine 5'-diphospho-glucuronosyltransferase genetic polymorphisms and response to cancer chemotherapy.UGT genomic diversity: beyond gene duplication.Predicting pharmacokinetics and drug interactions in patients from in vitro and in vivo models: the experience with 5,6-dimethylxanthenone-4-acetic acid (DMXAA), an anti-cancer drug eliminated mainly by conjugation.Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study.Clinical epidemiology and pharmacology of CYP2D6 inhibition related to breast cancer outcomes.Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: colon cancer family registry.Pharmacogenomics of human UDP-glucuronosyltransferase enzymes.UGT1A6 and UGT2B15 polymorphisms and acetaminophen conjugation in response to a randomized, controlled diet of select fruits and vegetablesFunctional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivors.Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancerAndrogens and doping tests: genetic variation and pit-falls.Protein kinase Cα and Src kinase support human prostate-distributed dihydrotestosterone-metabolizing UDP-glucuronosyltransferase 2B15 activity.Uridine diphosphate-glucuronosyltransferase 2B15 D85Y gene polymorphism is associated with lower prostate cancer risk: a systematic review and meta-analysis.A human minor histocompatibility antigen resulting from differential expression due to a gene deletionAssociation of uridine diphosphate-glucuronosyltransferase 2B gene variants with serum glucuronide levels and prostate cancer risk.The role of genetic variability in drug metabolism pathways in breast cancer prognosis.Variants in tamoxifen metabolizing genes: a case-control study of contralateral breast cancer risk in the WECARE study.Copy Number Variation of UGT 2B Genes in Indian Families Using Whole Genome Scans.Implication of Human UGT2B7, 2B15, and 2B17 in 19-Norandrosterone Metabolism.Potential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen.Prediction of deleterious non-synonymous single-nucleotide polymorphisms of human uridine diphosphate glucuronosyltransferase genes.Comprehensive variant screening of the UGT gene familyGenetic variation in androgen disposition: implications in clinical medicine including testosterone abuse.
P2860
Q24806179-D78F2A45-FAF3-4A7D-AD4F-A53D0FDA61DEQ28143359-D7C5E18E-B7D2-4EEA-A303-B8495FDA0440Q28248233-4497BE7D-A043-4D43-AC66-84CCED438162Q28303858-9C542E44-90D6-4510-906A-15301FA0B439Q28369530-DE0BFAA0-AF62-477A-A7F9-945E3C3BEFCEQ30629555-6B04A98C-4848-4420-A34F-84A0F023CB63Q33639755-23E5B961-B548-4137-8ED3-6629D7D8A69DQ33654727-D9FD3C5B-82CD-4108-9604-DB7B5BEA602CQ33714575-D8BCA6E1-10FD-44F9-97DE-602DA053C86FQ33724160-1613CDF2-864F-4191-90BF-298FB1C9F228Q33781188-DA04400E-3396-4450-9897-5CDD718A345CQ33954754-6AA7ACDD-C383-481A-8E75-E703CCE6E90CQ34067581-B40AEFFA-DF81-444C-B60A-682D07875B72Q34093111-4379BFEA-6E48-4672-8CA2-D15B79098577Q34350941-6E8F07B4-5E08-4C86-A6D9-FE31C33897FCQ34737080-1A631286-DAB4-4731-941A-017F50CCA0B0Q34951367-F273C6D4-8D61-41BE-9CF7-56BC70748FCDQ35008045-BFE8AB54-667F-4890-B607-7C7F87D3373FQ35009521-15512C7D-3CE9-4B1D-8168-C5A0DBE0C732Q35027930-289622D8-A2B9-4DF9-8D57-3BFDB2DD9278Q35051456-0AD5777B-53E1-49D3-B562-B625C24AD572Q35058455-1B74743B-6A36-47C0-8FF6-8E24F417B530Q35078297-1CAE0259-F20B-46DA-AC00-A6001F1DCB47Q35157993-9B4BA674-371A-4200-84E1-CB3832EE9DEFQ35187897-D8AAB8D6-2B2D-452A-99C0-966A6E1D430FQ35204531-9774AD7A-7E78-4767-BA7D-14387EB85526Q35749331-FA4C0F46-82E1-4363-823C-8D9829FB7090Q36087942-3D92F9CA-58BC-4D72-B8BC-A7FED1EB862DQ36097980-F75BA113-994A-42B9-8982-2DEDFB522025Q36367643-A4809138-22B5-44DD-B668-AD693A535C5CQ36370375-62A43EA5-CD6A-40A5-BABA-16B490AA2D92Q36476775-847B8B90-49DF-440D-8AC7-373F61A155FFQ36497088-AABCCE42-B3BA-4D35-B88E-41116EC73A0AQ36729040-76E28E93-6721-4C9D-B703-1F5AD9F8D0C4Q36764660-8FE95EBA-AABE-4044-B88A-62B944602A05Q36955916-8668FF34-9294-4DF6-811D-A44174C35FB1Q37221922-225FBB64-E138-4076-89FD-1ACBE5285E86Q37378051-BF818674-1DBC-4CFE-A96C-B8C6161D9555Q37418838-28F78C79-2F26-4BA4-853A-C0B0232FEB9BQ37481427-A049118D-469B-4886-8148-250F33EA0DCD
P2860
Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene
description
1997 nî lūn-bûn
@nan
1997 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Isolation and characterization ...... encoded by a polymorphic gene
@ast
Isolation and characterization ...... encoded by a polymorphic gene
@en
Isolation and characterization ...... encoded by a polymorphic gene
@nl
type
label
Isolation and characterization ...... encoded by a polymorphic gene
@ast
Isolation and characterization ...... encoded by a polymorphic gene
@en
Isolation and characterization ...... encoded by a polymorphic gene
@nl
prefLabel
Isolation and characterization ...... encoded by a polymorphic gene
@ast
Isolation and characterization ...... encoded by a polymorphic gene
@en
Isolation and characterization ...... encoded by a polymorphic gene
@nl
P2093
P3181
P1476
Isolation and characterization ...... encoded by a polymorphic gene
@en
P2093
P304
P3181
P356
10.1097/00008571-199708000-00007
P407
P577
1997-08-01T00:00:00Z